"AstraZeneca COVID 19 Vaccine"
Latest news and video coverage curated from trusted media outlets
GP nurse receives Oxford-AstraZeneca vaccine at surgery
Credit: PA - Press Association STUDIO Duration: 00:46Published
Covid-19: First vaccine shots likely on January 13th, countdown begins|Oneindia News
Credit: Oneindia Duration: 01:00Published
'Who will opt for vaccine...': Congress questions approval, slams govt
Credit: HT Digital Content Duration: 03:25Published
UK inoculates first patient with Oxford/AstraZeneca COVID-19 vaccine
Credit: Euronews English Duration: 01:37Published
Boris Johnson urges parents to send kids to school
Credit: Reuters - Politics Duration: 01:28Published
UK Becomes First Country to Authorize Oxford-AstraZeneca COVID-19 Vaccine
Credit: Wibbitz Top Stories Duration: 01:25Published
UK first to approve AstraZeneca/Oxford vaccine
Credit: Reuters Studio Duration: 01:32Published
UCHealth estimates a thousand participants in AstraZeneca COVID-19 vaccine trial by next week
Credit: 7News - The Denver Channel Duration: 02:00Published
Nations press on with AstraZeneca vaccine amid concerns
Credit: Reuters Studio Duration: 02:01Published
Credit: FRANCE 24 English Duration: 01:33Published
San Diegans can participate in AstraZeneca Coronavirus vaccine trial
Credit: ABC 10 News | San Diego Duration: 02:12Published
South Florida doctor optimistic about AstraZeneca COVID-19 vaccine
Credit: WPTV News | West Palm Beach Duration: 01:49Published
How AstraZeneca COVID-19 Vaccine Compares To Moderna, Pfizer
Credit: WBZ CBS Boston Duration: 03:00Published
Dow Jumps 210 Points On Vaccine News From AstraZeneca
Credit: Wochit Duration: 00:38Published
You Might Like
Pakistan approves emergency use of Oxford-AstraZeneca COVID-19 vaccineIn the first phase, the vaccine will be given to health workers and those aged 65 years and above, Mr. Umar said.
Astrazeneca vaccine gets approval in PakistanAstrazeneca's Covid-19 vaccine has been granted approval for emergency use in Pakistan, the country's health minister said on Saturday, the first vaccine against the disease to be given the green light..
India wants Serum Institute to lower price of AstraZeneca shot, say sourcesThe Indian government has been negotiating with the Serum Institute of India to bring down the price of AstraZeneca's Covid-19 vaccine, delaying the roll-out of the country's immunisation programme...
Brazil's Bolsonaro asks India to expedite Covid vaccine shipment as delays loomBrazilian President Jair Bolsonaro asked Prime Minister Narendra Modi to expedite a shipment of AstraZeneca's Covid-19 vaccine amid broader delays to the vaccine's arrival in Brazil, according to a..
UK dialysis patient among first to be vaccinated by Oxford-AstraZeneca COVID-19 vaccineThe UK's National Health Service (NHS) on Monday began rolling out the Oxford University vaccine developed by AstraZeneca as protection against COVID-19, with an 82-year-old Oxford-born dialysis..
'Covishield' ready to roll out in coming weeks: PoonawallaSerum Institute of India CEO Adar Poonawalla on Sunday said the Oxford-AstraZeneca Covid-19 vaccine 'Covishield' is ready to roll out in the coming weeks. Poonawalla's remarks came soon after after..
What you need to know about Oxford COVID-19 vaccineWith the UK giving the green light to the Covid-19 vaccine developed by Oxford University and drug maker AstraZeneca, India is also expected to follow suit soon as a meeting of the decision-making body..
UK approval of Oxford-AstraZeneca Covid-19 vaccine positive news, waiting for India's approval: Serum Institute
Oxford/AstraZeneca COVID-19 vaccine should be effective against new variant: ReportThe Oxford vaccine, which also has a tie-up with the Serum Institute of India, is expected to win approval in the UK before Thursday, speeding up the provision of the jab to the most vulnerable groups.
Also reported by •Mid-Day
Serum Institute seeks emergency use nod for CovishieldSerum Institute of India (SII) has applied for emergency use authorization of the first Made in India Covid-19 vaccine, Covishield. "As promised, before the end of 2020, @SerumInstIndia has applied..
COVID-19: After Pfizer, Pune-based SII seeks emergency use approval for Covishield vaccine in IndiaSII on Sunday applied to the DCGI seeking emergency use authorisation for Oxford-AstraZeneca Covid-19 vaccine in the country.
Citing tech issues, UN COVID-19 summit nixes Adar Poonawalla videoThe United Nations Covid-19 summit passed up a pre-recorded video message from Adar Poonawalla, CEO of the world's largest vaccine manufacturer, who was scheduled to speak in an afternoon session..
One crore healthcare workers will be 1st to get COVID-19 vaccine: GovernmentAn estimated one crore frontline health workers will receive the first dose of COVID-19 vaccine whenever it becomes available, with around 92 per cent of government hospitals and 55 per cent of private..
SII to seek emergency use authorisation for AstraZeneca COVID-19 vaccine in 2 weeks: Adar PoonawallaThe Serum Institute of India (SII) will seek emergency use authorisation for the AstraZeneca Covid 19 vaccine in about two weeks. Adar Poonawalla, Founder and CEO, SII said on Saturday that SII is..
Britain asks regulator to assess Oxford/AstraZeneca COVID-19 vaccine
India to consider clinical trials data of two full doses of AstraZeneca vaccineIndia will consider clinical trial data for the two full-dose Oxford-AstraZeneca Covid-19 vaccine candidate which the firm says has an efficacy of 62% and not the “half plus full” dose regime which..
1 crore healthcare workers to receive COVID-19 vaccine in first phase: ReportAn estimated one crore frontline health workers will receive the first dose of COVID-19 vaccine whenever it becomes available, with around 92 per cent of government hospitals and 55 per cent of private..
AstraZeneca COVID-19 vaccine can be 90% effective, results show
Also reported by •Hindu
Adar Poonawalla's SII aims to have 100m doses of AstraZeneca vaccine ready by DecemberSerum Institute of India (SII) is ramping up production of AstraZeneca's Covid-19 vaccine, aiming to have 100 million doses ready by December for a vaccination drive that could begin across India that..
India's Serum says produced 40 million doses of AstraZeneca Covid-19 vaccineSerum Institute of India, the world's largest vaccine producer, said on Thursday it has made 40 million doses of AstraZeneca's potential Covid-19 vaccine, and would soon begin making Novavax's rival..
Production of AstraZeneca COVID-19 vaccine begins in Australia
Oxford COVID vaccine prompts immune response among adults: AstraZenecaThe COVID-19 vaccine being developed by the University of Oxford produces a similar immune response in both older and younger adults British drugmaker AstraZeneca Plc said on Monday.
AstraZeneca COVID-19 vaccine trial back on track in US; Johnson & Johnson to followAstraZeneca Plc has resumed the US trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & Johnson is preparing to resume its trial on Monday or Tuesday, the companies..
AstraZeneca COVID-19 vaccine trial volunteer in Brazil diesBrazilian health authority Anvisa said on Wednesday that a volunteer in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and Oxford University had died but added that the trial would..
Also reported by •Indian Express •Hindu
Coronavirus | AstraZeneca COVID-19 vaccine trial Brazil volunteer dies, trial to continueBrazilian newspaper O Globo reported that the volunteer had been given a placebo and not the trial vaccine, citing unnamed sources
Also reported by •Indian Express
Astrazeneca Covid-19 vaccine trial in US expected to resume as early as this week
Can Centre procure Rs 80,000 crore to buy, distribute COVID-19 vaccine across India? SII CEO Adar PoonawallaOn September 16, the Drugs Controller General of India (DCGI) allowed the Serum Institute of India (SII) to restart its phase two and three clinical trials for the Oxford-AstraZeneca COVID-19 vaccine.